Literature DB >> 12367609

GABA(A) receptor delta subunit deletion prevents neurosteroid modulation of inhibitory synaptic currents in cerebellar neurons.

Stefano Vicini1, Gabriele Losi, Gregg E Homanics.   

Abstract

The delta subunit of the GABA(A) receptor has been reported to play a pivotal role in neurosteroid modulation. We investigated the action of the neurosteroid THDOC on GABA(A) receptor-mediated spontaneous inhibitory postsynaptic currents (sIPSCs) recorded in cerebellar neurons from delta subunit knockout mice. We observed that the neurosteroid failed to prolong IPSCs in granule neurons in cerebellar slices from these mice. This was in contrast to robust potentiation observed in wild-type mice. However, in stellate neurons, naturally devoid of delta subunit, a significant reduction of neurosteroid action on sIPSCs recorded in the presence of tetrodotoxin (mIPSCs) was also observed in mice that lack the delta subunit. Given the reported role of intracellular protein kinase C modulation of neurosteroid activity, we investigated the action of THDOC by recording sIPSCs and mIPSCs from delta-deficient mice with intracellular perfusion of a kinase stimulator. Phorbol-12-myristate-13-acetate (PMA) completely restored the action of the neurosteroid on synaptic currents in both granule and stellate neurons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12367609     DOI: 10.1016/s0028-3908(02)00126-0

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  29 in total

1.  Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors.

Authors:  Brandon M Stell; Stephen G Brickley; C Y Tang; Mark Farrant; Istvan Mody
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

2.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

Review 3.  Studies of ethanol actions on recombinant delta-containing gamma-aminobutyric acid type A receptors yield contradictory results.

Authors:  Cecilia M Borghese; R Adron Harris
Journal:  Alcohol       Date:  2007-05-23       Impact factor: 2.405

Review 4.  The role of ovarian hormone-derived neurosteroids on the regulation of GABAA receptors in affective disorders.

Authors:  Georgina MacKenzie; Jamie Maguire
Journal:  Psychopharmacology (Berl)       Date:  2014-01-09       Impact factor: 4.530

5.  GABAergic control of depression-related brain states.

Authors:  Bernhard Luscher; Thomas Fuchs
Journal:  Adv Pharmacol       Date:  2015-01-14

Review 6.  Genetic and Molecular Regulation of Extrasynaptic GABA-A Receptors in the Brain: Therapeutic Insights for Epilepsy.

Authors:  Shu-Hui Chuang; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2017-11-15       Impact factor: 4.030

7.  Dysfunctional astrocytic and synaptic regulation of hypothalamic glutamatergic transmission in a mouse model of early-life adversity: relevance to neurosteroids and programming of the stress response.

Authors:  Benjamin G Gunn; Linda Cunningham; Michelle A Cooper; Nicole L Corteen; Mohsen Seifi; Jerome D Swinny; Jeremy J Lambert; Delia Belelli
Journal:  J Neurosci       Date:  2013-12-11       Impact factor: 6.167

Review 8.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

9.  Isobolographic Analysis of Antiseizure Activity of the GABA Type A Receptor-Modulating Synthetic Neurosteroids Brexanolone and Ganaxolone with Tiagabine and Midazolam.

Authors:  Shu-Hui Chuang; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2019-12-16       Impact factor: 4.030

10.  Reduced conditioned fear response in mice that lack Dlx1 and show subtype-specific loss of interneurons.

Authors:  Rong Mao; Damon T Page; Irina Merzlyak; Carol Kim; Laurence H Tecott; Patricia H Janak; John L R Rubenstein; Mriganka Sur
Journal:  J Neurodev Disord       Date:  2009-07-11       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.